文献速递胸部CT

放射科医生在检测全身抗癌治疗相关间质性肺病中的作用:一篇教育性综述

The radiologist's role in detecting systemic anticancer therapy-related interstitial lung disease: an educational review.
PubMed 文献 · Insights Imaging · 2024-08-01

全身抗癌治疗(SACT)是药物性间质性肺病(ILD)的首要原因,随着新药获批,这一潜在致死性不良事件(AE)的发病率可能上升。早期发现SACT相关ILD可及时实施药物特异性管理建议,提高AE缓解可能性,并在某些情况下扩大患者未来癌症治疗选择。ILD需通过多学科团队协作排除其他病因来诊断,放射科医生在检测无症状(1级)ILD中起关键作用。

要点

  • 放射科医生对在严重程度/预后恶化前检测无症状(1级)ILD至关重要。
  • 高分辨率计算机断层扫描是检测ILD最合适的方法。
  • 药物性ILD是排除性诊断,需多学科团队参与。

核心结论

  • SACT相关ILD事件发病率可能随新方案获批而增加;本综述为放射科医生早期检测SACT相关ILD提供最佳实践建议。

研究设计与样本

  • 教育性综述;检索范围与纳入文献原文未报告。

关键影像表现/征象

  • ILD存在多种模式,可影响患者预后;四种主要模式包括急性间质性肺炎/急性呼吸窘迫综合征、机化性肺炎、过敏性肺炎和非特异性间质性肺炎,其独特影像学特征及更罕见模式在文中讨论。

诊断标准与关键数值

  • HRCT扫描层厚<2 mm是检测ILD最合适的方法。
  • 1级ILD无症状。
  • 药物性ILD是排除性诊断,需与患者多学科团队协作排除新发或加重呼吸体征和症状的其他可能病因。

临床应用与阅片要点

  • 计划性计算机断层扫描除评估肿瘤治疗反应外,应审查ILD的存在。
  • 怀疑ILD时,应立即申请高分辨率计算机断层扫描(HRCT)。
  • HRCT对随访ILD病程至关重要,可能有助于确定AE管理强度和再次挑战SACT的适当性(在药物特异性处方信息指示时)。
  • ILD事件应密切监测直至完全缓解。
  • 医生应在扫描申请单上标注已知有间质性肺病风险的全身抗癌治疗(SACT)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Systemic anticancer therapies (SACTs) are the leading cause of drug-induced interstitial lung disease (ILD). As more novel SACTs become approved, the incidence of this potentially life-threatening adverse event (AE) may increase. Early detection of SACT-related ILD allows for prompt implementation of drug-specific management recommendations, improving the likelihood of AE resolution and, in some instances, widening the patient's eligibility for future cancer treatment options. ILD requires a diagnosis of exclusion through collaboration with the patient's multidisciplinary team to rule out other possible etiologies of new or worsening respiratory signs and symptoms. At Grade 1, ILD is asymptomatic, and thus the radiologist is key to detecting the AE prior to the disease severity worsening. Planned computed tomography scans should be reviewed for the presence of ILD in addition to being assessed for tumor response to treatment, and when ILD is suspected, a high-resolution computed tomography (HRCT) scan should be requested immediately. An HRCT scan, with < 2-mm slice thickness, is the most appropriate method for detecting ILD. Multiple patterns of ILD exist, which can impact patient prognosis. The four main patterns include acute interstitial pneumonia / acute respiratory distress syndrome, organizing pneumonia, hypersensitivity pneumonitis, and non-specific interstitial pneumonia; their distinct radiological features, along with rarer patterns, are discussed here. Furthermore, HRCT is essential for following the course of ILD and might help to determine the intensity of AE management and the appropriateness of re-challenging with SACT, where indicated by drug-specific prescribing information. ILD events should be monitored closely until complete resolution. CRITICAL RELEVANCE STATEMENT: The incidence of potentially treatment-limiting and life-threatening systemic anticancer therapy-related interstitial lung disease (SACT-related ILD) events is likely increasing as more novel regimens become approved. This review provides best-practice recommendations for the early detection of SACT-related ILD by radiologists. KEY POINTS: Radiologists are crucial in detecting asymptomatic (Grade 1) ILD before severity/prognosis worsens. High-resolution computed tomography is the most appropriate method for detecting ILD. Drug-induced ILD is a diagnosis of exclusion, involving a multidisciplinary team. Familiarity with common HRCT patterns, described here, is key for prompt detection. Physicians should highlight systemic anticancer therapies (SACTs) with a known risk for interstitial lung diseases (ILD) on scan requisitions.

来源:Insights Imaging,查看原文。版权归原作者所有。

引用

  1. Dinkel J, Kneidinger N, Tarantino P, et al. The radiologist's role in detecting systemic anticancer therapy-related interstitial lung disease: an educational review. Insights Imaging. 2024. PMID: 39090512. doi:10.1186/s13244-024-01771-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。